Abstract
Transparency and evidence-based medicine are cornerstones of good publication practices (GPP), and concern publishers, editors, research investigators, and reviewers alike. Methods for implementing these principles within the framework of GPP are described. The main aspects include obtaining a Manuscript Agreement Contract, a Statement on Transparency of Authorship and a Declaration of Conflicts of Interest from the authors. Assessing whether a manuscript meets the requirements of EBM is demonstrated using the “7-D assessment”. The main purpose of this tool is to established that the (1) right Design, (2) right Diagnosis, (3) right Drug molecule, (4) right Dosage, (5) right Data, (6) right Deductions, and (7) right Documentation have been implemented in order to meet the objectives of the investigation. If the findings from any one of these assessments is questionable, the compliance of the research with EBM principles will be weakened and the reviewers and editors will make recommendations to the publisher accordingly. The guidelines described will help to provide a fair and transparent process of scientific publication and foster the freedom of clinical pharmacological research.
Highlights
Good publication practices (GPP) concern publishers, editors, research investigators, and reviewers alike
Assessing whether a manuscript meets the requirements of evidencebased medicine (EBM) is demonstrated using the “7-D assessment”
Clinical pharmacology manuscripts frequently contain recommendations for drug treatment as well as other information having a direct bearing on patient health and well-being
Summary
Good publication practices (GPP) concern publishers, editors, research investigators, and reviewers alike. Transparency and evidencebased medicine are cornerstones of good publication practices (GPP), and concern publishers, editors, research investigators, and reviewers alike.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have